Similar to CHMP5-depleted human T-ALL cells (Fig. 1), pathway analysis of these DEGs revealed downregulation of “MYC targets” in KO CD45.2+NGFR+ cells (Fig. 6e, f). This evidence concerns the gene CHMP5 and acute lymphoblastic leukemia.